1. Somatostatin (SRIF) exerts diverse physiological actions in the body including regulation of hormone and neurotransmitter release and neuronal firing activity. Analogs of SRIF are used clinically to treat tumors and cancers and to block the hypersecretion of growth hormone in acromegaly.
2. The recent cloning of five SRIF receptor subtypes has allowed for the identification of the molecular basis of the cellular actions of SRIF. The ligand binding domains and regions involved in coupling to G proteins and cellular effector systems are being identified and the processes by which SRIF inhibits cell growth and proliferation are being established. Furthermore, subtype selective agonists have been generated which are being used to investigate the specific biological roles of each SRIF receptor subtypes.
3. Such information will be useful in developing a new generation of SRIF drugs that could be employed to treat metabolic diseases, disorders of the gut, cancer and abnormalities in the central nervous system such as epilepsy and Alzheimer's disease.
Key wordssomatostatin receptors cDNA neurohormone GTP binding proteins cancer
Unable to display preview. Download preview PDF.
- Brazeau, P., Vale, W., Burgus, R., Ling, N., Rivier, J., and Guillemin, R. (1972). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.Science 12977–79.Google Scholar
- Buscail, L., Delesque, N., Esteve J.-P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, D., Bell, G. I., Liebow, C., Schally, A. V., Vaysse, N., and Susini, C. (1994). Stimulation of tyrosine phosphatase and inhibition of cell proliferation by SRIF analogues: mediation by human SRIF receptor subtypes SSTR1 and SSTR2.Proc. Natl. Acad. Sci. 912315–2319PubMedGoogle Scholar
- Buscail, L., Esteve, J. P., Saint-Laurent, N., Bertrand, V., Reisine, T., O'Carroll, A. M., Bell, G. I., Schally, A., Vaysse, N., and Susini, C. (1995). Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by SSTR2 and SSTR5 somatostatin receptor subtypes through different mechanisms.Proc. Natl. Acad. Sci. 921580–1584.PubMedGoogle Scholar
- Demchyshyn, L L., Srikant, C. B., Sunahara, R. K., Kent, G., Seeman, P., Van Tol, H. H. M., Panetta, R., Patel, Y. C., and Niznik, H. B. (1993). Cloning and expression of a human SRIF-14-selective receptor variant (SRIF receptor 4) located on chromosome 20.Mol. Pharmacol. 43894–901.PubMedGoogle Scholar
- Greenman, Y., and Melmed, S. (1994). Heterogeneous expression of two SRIF receptor subtypes in pituitary tumors.J. Clin. Endocrinol. Metabol. 78398–403.Google Scholar
- Hoyer, D.,et al. (1994). Molecular pharmacology of somatostatin receptors.Naunyn-Schmiedeberg's Arch. Pharmacol. 350441–453.Google Scholar
- Huany, Z., He, Y., Raynor, K., Tallent, M., Reisine, T., and Goodman, M. (1992). Side chain chiral methylated SRIF analog synthesis and conformational analysis.J. Am. Chem. Soc. 1149390–9401.Google Scholar
- Kong, H., DePaoli, A. M., Breder, C. D., Yasuda, K., Bell, G. I., and Reisine, T. (1994a). Differential expression of SRIF receptor subtypes SSTR1, SSTR2 and SSTR3 in adult rat brain, pituitary and adrenal gland. Analysis by RNA blotting andin situ hybridization.Neuroscience 59175–184.PubMedGoogle Scholar
- Kong, H., Raynor, K., and Reisine, T. (1994b). Amino acids in the cloned mouse kappa receptor that are necessary for high affinity agonist binding but not antagonist binding.Reg. Pep. 54155–156.Google Scholar
- Kubota, A., Yamada, Y., Kagimoto, S., Shimatsu, A., Imamura, M., Tsuda, K., Imura, H., Seino, S., and Seino, Y. (1994). Identification of SRIF receptor subtypes and an implication for the efficacy of SRIF analog SMS 201-955 in treatment of human endocrine tumors.J. Clin. Invest. 931321–1325.PubMedGoogle Scholar
- Lamberts, S., Krenning, E., and Reubi, J.-C. (1991). The role of SRIF and its analogs in the diagnosis and treatment of tumors.Endocrine Rev. 12450–482.Google Scholar
- Law, S., Zaina, S., Sweet, R., Yasuda, K., Bell, G. I., Stadel, J., and Reisine, T. (1994). Gia1 selectively couples the SRIF receptor subtype SSTR3 to adenylyl cyclase: Identification of the functional domains of this alpha subunit necessary for mediating SRIF's inhibition of cAMP formation.Mol. Pharmacol. 45587–590.PubMedGoogle Scholar
- O'Carroll, A.-M., Raynor, K., Lolait, S. J., and Reisine, T. (1994). Characterization of cloned human SRIF receptor SSTR5.Mol. Pharmacol. 48291–298.Google Scholar
- Panetta, R., Greenwood, M. T., Warszynska, A., Demchyshyn, L. L., Day, R., Niznik, H. B., Srikant, C. B., and Patel, Y. C. (1994). Molecular cloning, functional characterization and chromosomal localization of a human SRIF receptor (SRIF receptor type 5) with preferential affinity for SRIF 28.Mol. Pharmacol. 45417–427.PubMedGoogle Scholar
- Perez, J., Rigo, M., Kaupmann, C., Bruns, C., Yasuda, K., Bell, G. I., Lubbert, H., and Hoyer, D. (1994). Localization of SRIF (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain byin situ hybridization.Naunyn-Schmiedeberg's Arch. Pharmacol. 349145–160.Google Scholar
- Raynor, K., and Reisine, T. (1992). SRIF receptors.Crit. Rev. Neurobiol. 16273–289.Google Scholar
- Reisine, T., Tallent, M., and Dichter, M. (1994a). SRIF receptor subtypes endogenously expressed in AtT-20 cells couple to three different ionic currents.Soc. Neurosci. Abst. 20376.19135.Google Scholar
- Reisine, T., Heerding, J., and Raynor, K. (1994b). The third intracellular loop of the delta receptor is necessary for coupling to adenylyl cyclase and receptor desensitization.Reg. Pep. 54241–242.Google Scholar
- Veber, D., Saperstein, R., Nutt, R., Friedinger, R., Brady, S., Curley, P., Perlow, D., Palveda, W., Colton, C., Zacchei, A., Tocco, D., Hoff, D., Vandlen, R., Gerich, J., Hall, L., Mandarino, L., Cordes, E., Anderson, P., and Hirschmann, R. (1984). A superactive cyclic hexapeptide analog of SRIF.Life Sci. 34 1371–1378.PubMedGoogle Scholar
- Woulfe, D., and Reisine, T. (1994). Splice variants of SSTR2 differentially couple to adenylyl cyclase.Soc. Neurosci Abst. 20907.Google Scholar
- Yamada, Y., Reisine, T., Law, S. F., Ihara, Y., Kubota, A., Kagimoto, S., Seino, M., Seino, Y., Bell, G. I., and Seino, S. (1993a). SRIF receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase.Mol. Endocrinol. 62136–2142.Google Scholar
- Zeggari, M., Esteve, J., Rauly, I., Cambillau, C., Mazargull, H., Dufresne, M., Pradayrol, L., Chayvialle, J., Vaysse, N., and Susini, C. (1994). Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes.Biochem. J. 303441–448.PubMedGoogle Scholar